First Time Loading...

SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 121.15 INR -0.94% Market Closed
Updated: May 5, 2024

SeQuent Scientific Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SeQuent Scientific Ltd
Net Income (Common) Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
SeQuent Scientific Ltd
NSE:SEQUENT
Net Income (Common)
-₹1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
₹52.3B
CAGR 3-Years
34%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income (Common)
₹37.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
₹89.1B
CAGR 3-Years
55%
CAGR 5-Years
21%
CAGR 10-Years
13%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Net Income (Common)
₹29.7B
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
14%
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income (Common)
₹12.8B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is SeQuent Scientific Ltd's Net Income (Common)?
Net Income (Common)
-1.3B INR

Based on the financial report for Dec 31, 2023, SeQuent Scientific Ltd's Net Income (Common) amounts to -1.3B INR.

What is SeQuent Scientific Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-579%

Over the last year, the Net Income (Common) growth was -579%.